JP2024534824A5 - - Google Patents
Info
- Publication number
- JP2024534824A5 JP2024534824A5 JP2024511978A JP2024511978A JP2024534824A5 JP 2024534824 A5 JP2024534824 A5 JP 2024534824A5 JP 2024511978 A JP2024511978 A JP 2024511978A JP 2024511978 A JP2024511978 A JP 2024511978A JP 2024534824 A5 JP2024534824 A5 JP 2024534824A5
- Authority
- JP
- Japan
- Prior art keywords
- sequence
- seq
- polypeptide
- identity
- heavy chain
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163237071P | 2021-08-25 | 2021-08-25 | |
| US63/237,071 | 2021-08-25 | ||
| PCT/US2022/041471 WO2023038803A2 (en) | 2021-08-25 | 2022-08-25 | Engineered anti-her2 bispecific proteins |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024534824A JP2024534824A (ja) | 2024-09-26 |
| JP2024534824A5 true JP2024534824A5 (https=) | 2025-08-28 |
Family
ID=85506758
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024511978A Pending JP2024534824A (ja) | 2021-08-25 | 2022-08-25 | 操作された抗ｈｅｒ２二重特異性タンパク質 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20240392035A1 (https=) |
| EP (1) | EP4392064A4 (https=) |
| JP (1) | JP2024534824A (https=) |
| CN (1) | CN118119402A (https=) |
| WO (1) | WO2023038803A2 (https=) |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX2011010166A (es) * | 2009-04-07 | 2011-10-11 | Roche Glycart Ag | Anticuerpos biespecificos anti-erbb-3/anti-c-met. |
| AU2014357292B2 (en) * | 2013-11-27 | 2020-06-25 | Zymeworks Bc Inc. | Bispecific antigen-binding constructs targeting HER2 |
| EP3083696B1 (en) * | 2013-12-20 | 2018-02-14 | F.Hoffmann-La Roche Ag | Bispecific her2 antibodies and methods of use |
| SG11201608192SA (en) * | 2014-04-11 | 2016-10-28 | Medimmune Llc | Bispecific her2 antibodies |
| WO2020037150A2 (en) * | 2018-08-16 | 2020-02-20 | Denali Therapeutics Inc. | Engineered bispecific proteins |
| JP2021534220A (ja) * | 2018-08-22 | 2021-12-09 | デナリ セラピューティクス インコーポレイテッドDenali Therapeutics Inc. | 抗ｈｅｒ２ポリペプチド及びそれらの使用の方法 |
| AU2021224200A1 (en) * | 2020-02-19 | 2022-09-08 | Denali Therapeutics Inc. | Engineered anti-HER2 bispecific proteins |
-
2022
- 2022-08-25 WO PCT/US2022/041471 patent/WO2023038803A2/en not_active Ceased
- 2022-08-25 JP JP2024511978A patent/JP2024534824A/ja active Pending
- 2022-08-25 CN CN202280063237.7A patent/CN118119402A/zh active Pending
- 2022-08-25 US US18/685,583 patent/US20240392035A1/en active Pending
- 2022-08-25 EP EP22867902.3A patent/EP4392064A4/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021533779A5 (https=) | ||
| JP2022518925A5 (https=) | ||
| JP2023548443A5 (https=) | ||
| JP2023514371A5 (https=) | ||
| JP2021534762A5 (https=) | ||
| JP2019502712A5 (https=) | ||
| ES2334895T3 (es) | Mini-anticuerpo humano citotoxico para las celulas tumorales que expresan el receptor erbb2. | |
| JP2023181445A5 (https=) | ||
| JP2021522162A5 (https=) | ||
| JP2021159081A5 (https=) | ||
| KR20140067944A (ko) | 항체 중쇄불변부위의 이종이중체 고효율 형성을 유도하는 ch3 도메인 변이체 쌍, 이의 제조방법, 및 용도 | |
| JP2024532485A5 (https=) | ||
| JP2021534220A5 (https=) | ||
| JP2013515508A5 (https=) | ||
| JP2022512043A5 (https=) | ||
| JP2018504092A5 (https=) | ||
| EP2964676A1 (en) | Anti-c-met tandem fc bispecific antibodies | |
| JP2024501403A5 (https=) | ||
| JP2023532807A5 (https=) | ||
| JP2025038088A5 (https=) | ||
| JP2021521781A5 (https=) | ||
| JP2023506834A5 (https=) | ||
| CA3170338A1 (en) | Engineered anti-her2 bispecific proteins | |
| JP2023545707A5 (https=) | ||
| JP2025508867A5 (https=) |